Lapatinib and Trastuzumab With or Without Endocrine Therapy
Public ClinicalTrials.gov record NCT00548184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients
Study identification
- NCT ID
- NCT00548184
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Baylor Breast Care Center
- Other
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
- Endocrine Drug
- Lapatinib Drug
- Trastuzumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- Dec 31, 2010
- Completion
- Dec 31, 2013
- Last update posted
- Nov 6, 2019
2008 – 2014
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Cancer Center | Birmingham | Alabama | 35294 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bunting-Blaustein Cancer Research | Baltimore | Maryland | 21231-1000 | — |
| Mayo Clinic Cancer Center | Rochester | Minnesota | 55905 | — |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232-6868 | — |
| Baylor College of Medicine, Lester and Sue Smith Breast Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00548184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2019 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00548184 live on ClinicalTrials.gov.